Company Comparison
NeuroLink Therapeutics vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | NeuroLink Therapeutics | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge | Lagos, Nigeria |
| Founded | — | 2019 |
| Status | Active | Active |
| Last Funding Stage | Series A | Series B |
| Total Funding | $45M | $45M |
| Valuation | — | — |
What They Build
NeuroLink Therapeutics
A Cambridge-based biotech company developing neurological therapeutics and treatments.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
NeuroLink Therapeutics
No investors listed.
Sector Overlap
Both NeuroLink Therapeutics and 54gene operate in Biotech.
Browse all Biotech companies →Websites
Sponsored
AArchstone
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
LP portal & reportingCapital callsPortfolio tracking$297/moNo AUM fees
Now in alpha with select funds. 14-day trial available.